Instrument Inactif

Cours Trivascular Technologies Inc

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

TriVascular Technologies, Inc. Reports Third Quarter Financial Results	09/11/15
Preliminary Results of the LIFE Study Presented at VIVA 2015	03/11/15
Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015	03/11/15
Trivascular Technologies : Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourages Investors To Contact The Firm For Additional Information	29/10/15
TRIVASCULAR TECHNOLOGIES : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Endologix, Inc. May be Unfair to Shareholders	28/10/15

Dirigeants	Titre	Age	Depuis
John Onopchenko CEO	Chief Executive Officer	66	-
Vaseem Mahboob DFI	Director of Finance/CFO	55	03/02/16

Secteur

	Varia. 1 janv.	Capi.
STRYKER CORPORATION	+12,07 %	128 Md
SMITH & NEPHEW PLC	-9,04 %	10,65 Md
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0,91 %	8,82 Md
INSPIRE MEDICAL SYSTEMS, INC.	+16,72 %	7,19 Md
GLAUKOS CORPORATION	+25,15 %	4,99 Md
AXONICS, INC.	+7,17 %	3,4 Md
ENOVIS CORPORATION	-1,36 %	3,03 Md
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8,73 %	2,14 Md
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10,15 %	2 Md